Abstract
Decision letter: Epistatic mutations in PUMA BH3 drive an alternate binding mode to potently and selectively inhibit anti-apoptotic Bfl-1
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have